Cell and gene therapy has some wind beneath its sails. New regulatory frameworks from the Food and Drug Administration could help streamline development and manufacturing. Large pharma companies are investing in cell therapy start-ups. Will these shifts help the field overcome some long-standing hurdles? They’ll gather experts to discuss the landscape and explore what comes next.

Register here.